STERILE manufacturing specialist SCM Pharma is set to expand its vial filling capability after placing a major new order to help deal with several clinical trials and commercial supply contract wins.

Fill Finish Pharmaceutical CMOs · GlobeNewswire Inc. Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to ...

Fill-finish Pharmaceutical Contract Manufacturing Market · GlobeNewswire Inc. Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Fill-finish Pharmaceutical Contract Manufacturing Market - Global Forecast ...

-New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development- SPOKANE, Wash.–(BUSINESS WIRE)–February 12, 2025– Selkirk Pharma, Inc., ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global pharmaceutical capsule filling machines market is expected to grow from USD 646.2 million in 2025 to around USD 1,032.7 million by 2035, marking an ...

Over the next few years, we’ll likely be seeing more stories about things like Merck’s $90 million translational research center for scientists, entrepreneurs and venture capitalists; Sanofi’s ...

SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service ...

(MENAFN- GlobeNewsWire - Nasdaq) The fill-finish pharmaceutical contract manufacturing market is poised for growth, driven by the demand for specialized manufacturing of complex small molecule drugs.